These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 23270836)
1. Exploiting the synergistic effect of chitosan-EDTA conjugate with MSA for the early recovery from colitis. Singh K; Suri R; Tiwary AK; Rana V Int J Biol Macromol; 2013 Mar; 54():186-96. PubMed ID: 23270836 [TBL] [Abstract][Full Text] [Related]
2. Investigating the potential of Tamarindus indica pectin-chitosan conjugate for reducing recovery period in TNBS induced colitis. Sethi S; Khurana RK; Kamboj S; Sharma R; Singh A; Rana V Int J Biol Macromol; 2017 May; 98():739-747. PubMed ID: 28167113 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis. Onishi H; Oosegi T; Machida Y Int J Pharm; 2008 Jun; 358(1-2):296-302. PubMed ID: 18394832 [TBL] [Abstract][Full Text] [Related]
4. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats. Mura C; Nácher A; Merino V; Merino-Sanjuan M; Carda C; Ruiz A; Manconi M; Loy G; Fadda AM; Diez-Sales O Int J Pharm; 2011 Sep; 416(1):145-54. PubMed ID: 21723929 [TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis. Oosegi T; Onishi H; Machida Y Int J Pharm; 2008 Feb; 348(1-2):80-8. PubMed ID: 17714892 [TBL] [Abstract][Full Text] [Related]
6. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis. Bautzová T; Rabišková M; Béduneau A; Pellequer Y; Lamprecht A Eur J Pharm Biopharm; 2012 Jun; 81(2):379-85. PubMed ID: 22386911 [TBL] [Abstract][Full Text] [Related]
7. Luminal antioxidants enhance the effects of mesalamine in the treatment of chemically induced colitis in rats. Ancha HR; Kurella RR; McKimmey CC; Lightfoot S; Harty RF Exp Biol Med (Maywood); 2008 Oct; 233(10):1301-8. PubMed ID: 18703751 [TBL] [Abstract][Full Text] [Related]
8. Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats. Tozaki H; Fujita T; Odoriba T; Terabe A; Okabe S; Muranishi S; Yamamoto A J Pharm Pharmacol; 1999 Oct; 51(10):1107-12. PubMed ID: 10579681 [TBL] [Abstract][Full Text] [Related]
9. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles. Mladenovska K; Raicki RS; Janevik EI; Ristoski T; Pavlova MJ; Kavrakovski Z; Dodov MG; Goracinova K Int J Pharm; 2007 Sep; 342(1-2):124-36. PubMed ID: 17590293 [TBL] [Abstract][Full Text] [Related]
10. Co-delivery of zinc and 5-aminosalicylic acid from alginate/N-succinyl-chitosan blend microspheres for synergistic therapy of colitis. Duan H; Lü S; Qin H; Gao C; Bai X; Wei Y; Wu X; Liu M; Zhang X; Liu Z Int J Pharm; 2017 Jan; 516(1-2):214-224. PubMed ID: 27851980 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis. Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235 [TBL] [Abstract][Full Text] [Related]
12. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. Tozaki H; Odoriba T; Okada N; Fujita T; Terabe A; Suzuki T; Okabe S; Muranishi S; Yamamoto A J Control Release; 2002 Jul; 82(1):51-61. PubMed ID: 12106976 [TBL] [Abstract][Full Text] [Related]
13. Chitosan films: crosslinking with EDTA modifies physicochemical and mechanical properties. Singh K; Suri R; Tiwary AK; Rana V J Mater Sci Mater Med; 2012 Mar; 23(3):687-95. PubMed ID: 22286228 [TBL] [Abstract][Full Text] [Related]
14. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation. Rabišková M; Bautzová T; Gajdziok J; Dvořáčková K; Lamprecht A; Pellequer Y; Spilková J Int J Pharm; 2012 Jan; 422(1-2):151-9. PubMed ID: 22079717 [TBL] [Abstract][Full Text] [Related]
15. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules. Smrdel P; Cerne M; Bogataj M; Urleb U; Mrhar A J Microencapsul; 2010; 27(7):572-82. PubMed ID: 20690794 [TBL] [Abstract][Full Text] [Related]
16. Site Targeted Press Coated Delivery of Methylprednisolone Using Eudragit RS 100 and Chitosan for Treatment of Colitis. Jagdale S; Chandekar A Recent Pat Antiinfect Drug Discov; 2016; 11(1):32-43. PubMed ID: 26377799 [TBL] [Abstract][Full Text] [Related]
17. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis. Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681 [TBL] [Abstract][Full Text] [Related]
18. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Fiorucci S; Orlandi S; Mencarelli A; Caliendo G; Santagada V; Distrutti E; Santucci L; Cirino G; Wallace JL Br J Pharmacol; 2007 Apr; 150(8):996-1002. PubMed ID: 17339831 [TBL] [Abstract][Full Text] [Related]
19. Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats. Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L Bioorg Med Chem; 2007 Jul; 15(14):4903-9. PubMed ID: 17499512 [TBL] [Abstract][Full Text] [Related]
20. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery. Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]